Vaccine advisers to the FDA voted 16-1 on Thursday to endorse Paxlovid for high-risk COVID-19 patients, but experts later said there’s not enough data to determine precisely who would benefit most from the drug.
last October found Black and Latino patients were as much as 36% less likely to be prescribed the drug than white patients even when they were immunocompromised.
And Test to Treat sites aimed at helping hard-hit communities access Paxlovid were often not accessible to rural residents and others most in need, according to aThere’s not a good understanding [of Paxlovid] among the medical community" leading to an "actual dissuading of patients from taking an effective and safe drug that could save their life," said Sankar Swaminathan, an FDA panelist and infectious disease specialist at the University of Utah who voted to recommend full...
Swaminathan said he’s had a "distressingly large number of patients" — including those with cancer — say they were told not to take Paxlovid because of COVID rebound, in which people test positive or have symptoms after completing a course of the drug.Terry Gillespie, a patient representative and the lone member of the expert panel who voted against full approval, told panelists she’s had COVID multiple times and has one lung yet — has never been offered Paxlovid.
"I’m kind of concerned about the doctors knowing actually when to prescribe it to somebody, say, like me," she said.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. FDA advisers vote in favor of full approval for Pfizer's COVID pill PaxlovidAdvisers to the U.S. health regulator on Thursday voted in favor of recommending a full approval for Pfizer's COVID-19 pill Paxlovid in adults at high risk of progression to severe disease.
Read more »
FDA advisers vote in favor of full approval for Pfizer's COVID pill PaxlovidU.S. health regulators voted in favor of a full approval for Pfizer's COVID pill Paxlovid. This pill will will help adults who are at high risk of progression to severe virus.
Read more »
Purina recalls more dry dog food; See if your dog’s food is on listThe Purina recall, due to potentially hazardous levels of Vitamin D, marks the company's second recall of select dry dog food products in just over a month.
Read more »
COVID-19 pill Paxlovid moves closer to full FDA approvalPfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers, clearing the way for its full approval by the FDA. The medication has been used by millions of Americans since it was granted emergency use authorization in 2021.
Read more »
FDA panel to meet Thursday to discuss full approval of PaxlovidA Food and Drug Administration committee is set to meet Thursday to decide whether the regulator should grant full approval to Paxlovid, the antiviral pill...
Read more »
Researchers Are Getting Closer to Learning How to Treat and Prevent Long COVIDPromising drugs include metformin and Paxlovid
Read more »